ProductUpdated on 19 September 2024
Lisdexamfetamine dimesylate active pharmaceutical ingredient
About
Lisdexamfetamine dimesylate (Vyvanse) is in short supply in the U.S. and other locations. This product is utilized for ADHD and Binge Eating Disorder. We have all state and DEA licenses for a Schedule II controlled substance. Our product meets the highest standards of quality and safety.
Similar opportunities
Product
Lisdexamfetamine dimesylate active pharmaceutical ingredient
- Laboratory industry
- Pharmaceutical industry
Glenda Rosado
Quality Coordinator at Skalar Pharma LLC
Guayama, Puerto Rico
Product
EARLY DETECTION OF VOMITING BEHAVIOR IN PATIENTS WITH EATING DISORDERS
- Other
- Health innovation
- Pharmaceutical industry
Ana Somé
Technology Transfer Manager - Specialist on Intellectual Property at Universidad de Málaga
Málaga, Spain
Service
Import and Export for IMPs and Commercials
Jürgen Fuchs
Head of Business Development at ABF Pharmaceutical Services GmbH
Vienna, Austria